BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow-to-Debt Ratio
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow-to-Debt Ratio of 0.18x as of September 2025, meaning its operating cash flow of Rs149.66 Million could theoretically repay 0% of its total liabilities (Rs844.30 Million) in one year. See BALAXI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BALAXI PHARMACEUTICALS LIMITED Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for BALAXI PHARMACEUTICALS LIMITED across 13 annual periods. Also explore BALAXI net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BALAXI PHARMACEUTICALS LIMITED (2013–2025)
Year-by-year debt coverage analysis for BALAXI PHARMACEUTICALS LIMITED. For market capitalisation and broader financial context, see BALAXI PHARMACEUTICALS LIMITED (BALAXI) total market value.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.48x | Rs-377.82 Million | Rs786.06 Million | ▼ -662.8% |
| 2024 | 0.09x | Rs48.66 Million | Rs569.79 Million | ▼ -20.2% |
| 2023 | 0.11x | Rs60.75 Million | Rs567.89 Million | ▼ -80.2% |
| 2022 | 0.54x | Rs341.44 Million | Rs633.07 Million | ▲ +603623.0% |
| 2021 | 0.00x | Rs31.00K | Rs347.00 Million | ▲ +100.0% |
| 2020 | -1.71x | Rs-140.62 Million | Rs82.25 Million | ▼ -193.5% |
| 2019 | -0.58x | Rs-15.07 Million | Rs25.87 Million | ▲ +88.7% |
| 2018 | -5.14x | Rs-6.78 Million | Rs1.32 Million | ▼ -12.7% |
| 2017 | -4.56x | Rs-9.91 Million | Rs2.17 Million | ▲ +83.4% |
| 2016 | -27.48x | Rs-1.16 Million | Rs42.12K | ▼ -159.4% |
| 2015 | 46.27x | Rs2.11 Million | Rs45.65K | ▲ +8299.8% |
| 2014 | -0.56x | Rs-2.39 Million | Rs4.24 Million | ▼ -184.5% |
| 2013 | 0.67x | Rs3.25 Million | Rs4.86 Million | — |